Rictor regulates cell migration by suppressing RhoGDI2

Oncogene

Volumn 32, Issue 20, 2013, Pages 2521-2526

  Agarwal, N K ^a   Chen, C H ^a,b   Cho, H ^a,b   Boulbes D R ^a   Spooner, E ^c   Sarbassov, D D ^a,b  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF TEXAS   (United States)

^c WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH   (United States)

Author keywords

Cell migration; Rho proteins; RhoGDI2; Rictor (rapamycin insensitive companion of mTOR)

Indexed keywords

CELL PROTEIN; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 1; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 2; PROTEIN CDC42; RAC PROTEIN; RHO FACTOR; RHO GUANINE NUCLEOTIDE DISSOCIATION INHIBITOR 2; RICTOR PROTEIN; SIN1 PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL MIGRATION; FUNCTIONAL PROTEOMICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; UPREGULATION;

ANIMALS; CARRIER PROTEINS; CDC42 GTP-BINDING PROTEIN; CELL MOVEMENT; CELLS, CULTURED; FIBROBLASTS; GENE KNOCKDOWN TECHNIQUES; HUMANS; MICE; MULTIPROTEIN COMPLEXES; NEUROPEPTIDES; PROTEINS; PROTEOMICS; RAC GTP-BINDING PROTEINS; RHO GUANINE NUCLEOTIDE DISSOCIATION INHIBITOR BETA; TOR SERINE-THREONINE KINASES; UP-REGULATION;

DICTYOSTELIUM; MAMMALIA; RAPTORES;

EID: 84878020578     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2012.287     Document Type: Article

References (33)

1. Sarbassov DD, Ali SM, Sabatini DM. Growing roles for the mTOR pathway. Curr Opin Cell Biol 2005; 17: 596-603. (Pubitemid 41540408)
2. Zoncu R, Efeyan A, Sabatini DM. mTOR: from growth signal integration to cancer, diabetes and ageing. Nat Rev Mol Cell Biol 2011; 12: 21-35.
3. Sarbassov DD, Ali SM, Kim DH, Guertin DA, Latek RR, Erdjument-Bromage H et al. Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptorindependent pathway that regulates the cytoskeleton. Curr Biol 2004; 14: 1296-1302. (Pubitemid 38991819)
4. Jacinto E, Loewith R, Schmidt A, Lin S, Ruegg MA, Hall A et al. Mammalian TOR complex controls the actin cytoskeleton and is rapamycin insensitive. Nat Cell Biol 2004; 6: 1122-1128. (Pubitemid 39468014)
5. Jacinto E, Facchinetti V, Liu D, Soto N, Wei S, Jung SY et al. SIN1/MIP1 maintains rictor-mTOR complex integrity and regulates Akt phosphorylation and substrate specificity. Cell 2006; 127: 125-137. (Pubitemid 44466632)
6. Pearce LR, Komander D, Alessi DR. The nuts and bolts of AGC protein kinases. Nat Rev Mol Cell Biol 2010; 11: 9-22.
7. Aimbetov R, Chen CH, Bulgakova O, Abetov D, Bissenbaev AK, Bersimbaev RI et al. Integrity of mTORC2 is dependent on the rictor Gly-934 site. Oncogene 2012; 31: 2115-2120.
8. Boulbes DR, Shaiken T, Sarbassov dos D. Endoplasmic reticulum is a main localization site of mTORC2. Biochem Biophys Res Commun 2011; 413: 46-52.
9. Chen CH, Shaikenov T, Peterson TR, Aimbetov R, Bissenbaev AK, Lee SW et al. ER stress inhibits mTORC2 and Akt signaling through GSK-3beta-mediated phosphorylation of rictor. Sci Signal 2011; 4; ra10.
10. Oh WJ, Wu CC, Kim SJ, Facchinetti V, Julien LA, Finlan M et al. mTORC2 can associate with ribosomes to promote cotranslational phosphorylation and stability of nascent Akt polypeptide. EMBO J 2010; 29: 3939-3951.
11. Zinzalla V, Stracka D, Oppliger W, Hall MN. Activation of mTORC2 by association with the ribosome. Cell 2011; 144: 757-768.
12. Chen MY, Long Y, Devreotes PN. A novel cytosolic regulator, Pianissimo, is required for chemoattractant receptor and G protein-mediated activation of the transmembrane domain adenylyl cyclase in Dictyostelium. Genes Dev 1997; 11: 3218-3231. (Pubitemid 27528061)
13. Masri J, Bernath A, Martin J, Jo OD, Vartanian R, Funk A et al. mTORC2 activity is elevated in gliomas and promotes growth and cell motility via overexpression of rictor. Cancer Res 2007; 67: 11712-11720.
14. Liu L, Das S, Losert W, Parent CA. mTORC2 regulates neutrophil chemotaxis in a cAMP- and RhoA-dependent fashion. Dev Cell 2010; 19: 845-857.
15. Hagan GN, Lin Y, Magnuson MA, Avruch J, Czech MP. A Rictor-Myo1c complex participates in dynamic cortical actin events in 3T3-L1 adipocytes. Mol Cell Biol 2008; 28: 4215-4226. (Pubitemid 351904945)
16. McDonald PC, Oloumi A, Mills J, Dobreva I, Maidan M, Gray V et al. Rictor and integrin-linked kinase interact and regulate Akt phosphorylation and cancer cell survival. Cancer Res 2008; 68: 1618-1624. (Pubitemid 351416544)
17. Dihazi H, Asif AR, Agarwal NK, Doncheva Y, Muller GA. Proteomic analysis of cellular response to osmotic stress in thick ascending limb of Henle's loop (TALH) cells. Mol Cell Proteomics 2005; 4: 1445-1458. (Pubitemid 41555471)
18. Dovas A, Couchman JR. RhoGDI: multiple functions in the regulation of Rho family GTPase activities. Biochem J. 2005; 390(Part 1): 1-9. (Pubitemid 41192225)
19. Gildea JJ, Seraj MJ, Oxford G, Harding MA, Hampton GM, Moskaluk CA et al. RhoGDI2 is an invasion and metastasis suppressor gene in human cancer. Cancer Res 2002; 62: 6418-6423. (Pubitemid 35364098)
20. Said N, Theodorescu D. Pathways of metastasis suppression in bladder cancer. Cancer Metastasis Rev 2009; 28: 327-333.
21. Scheffzek K, Stephan I, Jensen ON, Illenberger D, Gierschik P. The Rac-RhoGDI complex and the structural basis for the regulation of Rho proteins by RhoGDI. Nat Struct Biol 2000; 7: 122-126. (Pubitemid 30082509)
22. Zhang Y, Rivera Rosado LA, Moon SY, Zhang B. Silencing of D4-GDI inhibits growth and invasive behavior in MDA-MB-231 cells by activation of Rac-dependent p38 and JNK signaling. J Biol Chem 2009; 284: 12956-12965.
23. Jaffe AB, Hall A. Rho GTPases: biochemistry and biology. Annu Rev Cell Dev Biol 2005; 21: 247-269. (Pubitemid 41740635)
24. Theodorescu D, Sapinoso LM, Conaway MR, Oxford G, Hampton GM, Frierson Jr HF. Reduced expression of metastasis suppressor RhoGDI2 is associated with decreased survival for patients with bladder cancer. Clin Cancer Res 2004; 10: 3800-3806. (Pubitemid 38697615)
25. Imai K, Kijima T, Noda Y, Sutoh K, Yoda K, Adachi HA et al. Dissociation inhibitor is involved in cytokinesis of Dictyostelium. Biochem Biophys Res Commun 2002; 296: 305-312.
26. Moissoglu K, McRoberts KS, Meier JA, Theodorescu D, Schwartz MA. Rho GDP dissociation inhibitor 2 suppresses metastasis via unconventional regulation of RhoGTPases. Cancer Res 2009; 69: 2838-2844.
27. Khyrul WA, LaLonde DP, Brown MC, Levinson H, Turner CE. The integrin-linked kinase regulates cell morphology and motility in a rho-associated kinase-dependent manner. J Biol Chem 2004; 279: 54131-54139. (Pubitemid 40053149)
28. Kim SV, Flavell RA. Myosin I: from yeast to human. Cell Mol Life Sci 2008; 65: 2128-2137.
29. Gao D, Wan L, Inuzuka H, Berg AH, Tseng A, Zhai B et al. Rictor forms a complex with Cullin-1 to promote SGK1 ubiquitination and destruction. Mol Cell 2010; 39: 797-808.
30. Chan CH, Lee SW, Li CF, Wang J, Yang WL, Wu CY et al. Deciphering the transcriptional complex critical for RhoA gene expression and cancer metastasis. Nat Cell Biol 2010; 12: 457-467.
31. Boulbes D, Chen CH, Shaikenov T, Agarwal NK, Peterson TR, Addona TA et al. Rictor phosphorylation on the Thr-1135 site does not require mammalian target of rapamycin complex 2. Mol Cancer Res 2010; 8: 896-906.
32. Klemm EJ, Spooner E, Ploegh HL. The dual role of ancient ubiquitous protein 1 (AUP1) in lipid droplet accumulation and ER protein quality control. J Biol Chem 2011; 286: 37602-37614.
33. Sarbassov DD, Guertin DA, Ali SM, Sabatini DM. Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science 2005; 307: 1098-1101. (Pubitemid 40262113)